Insider Transactions in Q3 2025 at Inozyme Pharma, Inc. (INZY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Sanjay Subramanian SVP, CFO & Head of BD |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
39,701
-100.0%
|
$158,804
$4.0 P/Share
|
|
Jul 01
2025
|
Axel Bolte |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
423,926
-100.0%
|
$1,695,704
$4.0 P/Share
|
|
Jul 01
2025
|
Matthew Winton COO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,743
-100.0%
|
$86,972
$4.0 P/Share
|
|
Jul 01
2025
|
Douglas A Treco CEO & Chairman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
43,861
-100.0%
|
$175,444
$4.0 P/Share
|
|
Jul 01
2025
|
Robert Lorne Hopfner |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,494,851
-100.0%
|
$17,979,404
$4.0 P/Share
|